| Press Release | VivaGel BV US FDA Appeal Outcome (ASX Announcement) | Starpharma | 0 | 1 year 2 months ago |
| Press Release | Starpharma receives $7.1M R&D tax incentive refund (ASX announcement) | Starpharma | 0 | 2 years 4 months ago |
| Press Release | Resignation of CFO / Company Secretary | Starpharma | 0 | 2 years 4 months ago |
| Press Release | Positive AZD0466 clinical data presented by AstraZeneca (ASX Announcement) | Starpharma | 0 | 2 years 5 months ago |
| Press Release | Starpharma signs new DEP agreement with MSD (ASX Announcement) | Starpharma | 0 | 2 years 7 months ago |
| Press Release | Starpharma presents additional clinical data for DEP cabazitaxel in prostate cancer (ASX Announcement) | Starpharma | 0 | 2 years 7 months ago |
| Press Release | Starpharma presents promising additional clinical data for DEP cabazitaxel in prostate cancer | Starpharma | 0 | 2 years 8 months ago |
| Press Release | Starpharma signs new DEP agreement with MSD | Starpharma | 0 | 2 years 9 months ago |
| Press Release | VIRALEZE relaunched by LloydsPharmacy in the UK (ASX Announcement) | Starpharma | 0 | 2 years 10 months ago |
| Press Release | SPL7013 in VIRALEZE virucidal against influenza A and B (ASX Announcement) | Starpharma | 0 | 2 years 12 months ago |
| Press Release | Starpharma to present DEP at Boston ADC summit (ASX Announcement) | Starpharma | 0 | 3 years 2 weeks ago |
| Press Release | VIRALEZE to relaunch in the UK (ASX Announcement) | Starpharma | 0 | 3 years 1 month ago |
| Press Release | Response to media article (ASX Announcement) | Starpharma | 0 | 3 years 2 months ago |
| Press Release | SPL7013 in VIRALEZE virucidal against Omicron (ASX Announcement) | Starpharma | 0 | 3 years 2 months ago |
| Press Release | Dr Jeff Davies appointed as non-executive director (ASX Announcement) | Starpharma | 0 | 3 years 2 months ago |
| Press Release | Starpharma receives $7.7M R&D tax incentive refund (ASX Announcement) | Starpharma | 0 | 3 years 2 months ago |
| Press Release | VIRALEZE sales and distribution in Saudi Arabia and GCC (ASX Announcement) | Starpharma | 0 | 3 years 2 months ago |
| Press Release | Starpharma Interim Report and Half-Year Financial Results (ASX Announcement) | Starpharma | 0 | 3 years 2 months ago |
| Press Release | VIRALEZE antiviral nasal spray registered in Saudi Arabia (ASX Announcement) | Starpharma | 0 | 3 years 4 months ago |
| Press Release | VIRALEZE successfully launched in Vietnam (ASX Announcement) | Starpharma | 0 | 3 years 5 months ago |
| Press Release | Starpharma signs DEP Research Agreement with US Biopharma Co (ASX Announcement) | Starpharma | 0 | 3 years 5 months ago |
| Press Release | VIRALEZE distribution agreement and launch in Vietnam (ASX Announcement) | Starpharma | 0 | 3 years 5 months ago |
| Press Release | VIRALEZE registered in Vietnam with launch this week (ASX Announcement) | Starpharma | 0 | 3 years 5 months ago |
| Press Release | Starpharma to present DEP at US Drug Delivery Conference (ASX Announcement) | Starpharma | 0 | 3 years 6 months ago |
| Press Release | VIRALEZE distribution and supply to Vietnam (ASX Announcement) | Starpharma | 0 | 3 years 6 months ago |
